UK's NICE Recommends Use of Genomic Health's OncoType DX in Draft Guidance
February 19, 2013
Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Genomic Health's Q1 Revenues Climb 17 Percent, Net Loss Turns to Profit
May 3, 2012 / GenomeWeb Daily News - FDA Clears ASI Gene Scanner as PGx Tool for NSCLC
February 15, 2013 / GenomeWeb Daily News - Genotox Labs Announced as First Customer for Translational Software’s PGx Interpretation, Integration Service
February 13, 2013 / Pharmacogenomics Reporter - JP Morgan Healthcare Conference, Day One: Myriad Genetics; Bruker; Genomic Health; Qiagen; Waters
January 8, 2013 / GenomeWeb Daily News - LabCorp Licenses Sequella Technology for TB Assay Development
October 22, 2012 / GenomeWeb Daily News
.png)
No hay comentarios:
Publicar un comentario